Deirdre Colao
Family · Phoenix, AZNPI 1437672680
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.9% of the total across 64 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by Blue Earth Diagnostics at 26.5% of the total. 2025 is the largest year on record at $810, 2.0 times the $404 reported in 2021.
Across 64 payments — averaging $28.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Blue Earth Diagnostics$481
- Siemens Medical Solutions USA, Inc.$277
- Myriad Genetic Laboratories, Inc.$170
- Pfizer$143
- Gilead$100
- Novartis$89
- plus $554 from 14 others
What the payments were for
- Food & beverage$1,79699%
- Entertainment$201%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Blue Earth Diagnostics | 17 | $481 |
| Siemens Medical Solutions USA, Inc. | 4 | $277 |
| Myriad Genetic Laboratories, Inc. | 8 | $170 |
| Pfizer | 7 | $143 |
| Gilead | 1 | $100 |
| Novartis | 4 | $89 |
| AbbVie | 3 | $70 |
| Verity Pharmaceuticals Inc. | 3 | $61 |
| AstraZeneca | 2 | $59 |
| Sumitomo Pharma America, Inc. | 2 | $56 |
| Progenics Pharmaceuticals, Inc. | 2 | $55 |
| Novocure Inc. | 2 | $44 |
| Genmab U.S., Inc. | 1 | $34 |
| Astellas Pharma US Inc | 2 | $31 |
| Daiichi Sankyo Inc. | 1 | $30 |
| Octapharma USA, Inc. | 1 | $27 |
| Abbott | 1 | $26 |
| Johnson & Johnson | 1 | $22 |
| Accuray Incorporated | 1 | $20 |
| Argentum Medical | 1 | $20 |
How this compares
$1,815 in reported general payments places this provider in the 80th percentile of 4,119 family providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 303 | $3,658 |
| Pentoxifylline | 12 | $880 |
| Pilocarpine Hcl | 12 | $459 |
| Methylprednisolone | 31 | $269 |
Paid to pharmacies, not to this prescriber.
Other family in Phoenix
- Kimberly HallaPhoenix$332K
- Audrey StevensonPhoenix$83K
- Rebekah EdwardsPhoenix$51K
- Tirsa QuartulloPhoenix$31K
- Jessica AcostaPhoenix$30K
- Stephanie JohnstonPhoenix$25K
- Kelly MarcelloPhoenix$23K
- Judith BergmanPhoenix$22K
- Lauren BonnerPhoenix$22K
- Rita GonzalezPhoenix$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.